Three consecutive monthly injections as the loading phase injection is a protocol frequently used for AMD, and it is also used for DME treatments to avoid such problems.[24] Although the effectiveness of anti-VEGF agents for DME is well known, it is important to know that we cannot treat all patients with only this therapy. This evidence concerns the gene VEGFA and age-related macular degeneration.